Valuation: Medios AG

Market Cap 248M 278M 229M 208M 388M 26.36B 395M 2.76B 1.09B 13.81B 1.04B 1.02B 43.55B P/E 2026 *
12x
P/E 2027 * 8.43x
Enterprise Value 344M 385M 318M 288M 539M 36.57B 548M 3.82B 1.51B 19.16B 1.45B 1.41B 60.4B EV / Sales 2026 *
0.16x
EV / Sales 2027 * 0.14x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week-2.50%
Current month-9.32%
1 month+1.20%
3 months-19.30%
6 months-23.68%
Current year-30.11%
1 week 10.1
Extreme 10.1
10.52
1 month 10.1
Extreme 10.1
11.52
Current year 9.98
Extreme 9.98
17.44
1 year 9.98
Extreme 9.98
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
12/8/26 Buy

Chief Financial Officer

3,500 0.0137%
4/2/26 Sell

Chief Executive Officer

13,638 0.0535%
22/1/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-2.50%-20.06%-28.63% 278M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.68%+1.70%+31.21%+60.94% 400.46B
Weighted average by Cap. -0.26%+2.66%+40.99%+82.12%

Financials

2026 *2027 *
Net sales 2.17B 2.43B 2B 1.81B 3.39B 230B 3.45B 24.1B 9.54B 121B 9.11B 8.92B 381B 2.25B 2.52B 2.08B 1.88B 3.52B 239B 3.58B 24.98B 9.89B 125B 9.44B 9.24B 395B
Net income 20.76M 23.25M 19.18M 17.38M 32.52M 2.21B 33.06M 231M 91.39M 1.16B 87.26M 85.41M 3.65B 29.51M 33.04M 27.26M 24.7M 46.21M 3.14B 46.98M 328M 130M 1.64B 124M 121M 5.18B
Net Debt 96M 108M 88.68M 80.37M 150M 10.2B 153M 1.07B 423M 5.35B 403M 395M 16.86B 56.62M 63.4M 52.3M 47.4M 88.68M 6.02B 90.14M 629M 249M 3.15B 238M 233M 9.94B
Projected Income Statement - Annual - Medios AG
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
989
Date Price Change Volume
23/10/26 €10.12 -0.78% 8,920
22/10/26 €10.20 -1.92% 24,384
21/10/26 €10.40 -0.38% 3,554
20/10/26 €10.44 +2.35% 18,322
19/10/26 €10.20 -1.73% 14,977
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medios AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.12EUR
Average target price
20.25EUR
Spread / Average Target
+100.10%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Medios AG
  1. Stock Market
  2. Stocks
  3. ILM1 Stock